Carlton Dicarlo
Physician Assistant · Palatka, FLNPI 1962473389
Payments from drug & device makers
Across 347 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$2K
- AbbVie$750
- Novo Nordisk$701
- AstraZeneca$699
- Bayer$229
- Sanofi-aventis U.S. LLC$187
- plus $2K from 34 others
What the payments were for
- Food & beverage$5,90699%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 119 | $1,617 |
| AbbVie | 49 | $750 |
| Novo Nordisk | 41 | $701 |
| AstraZeneca | 33 | $699 |
| Bayer | 13 | $229 |
| Sanofi-aventis U.S. LLC | 10 | $187 |
| Mylan Specialty L.p. | 5 | $122 |
| Idorsia Pharmaceuticals US Inc | 7 | $120 |
| Exact Sciences | 6 | $97 |
| Merck | 6 | $97 |
| Radius Health, Inc. | 4 | $94 |
| GSK | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Pfizer | 5 | $85 |
| Ultragenyx Pharmaceutical Inc. | 1 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $71 |
| Gilead | 2 | $68 |
| Corcept Therapeutics | 3 | $65 |
| Amgen | 2 | $65 |
| Phathom Pharmaceuticals, Inc. | 1 | $62 |
| Sunovion Pharmaceuticals Inc. | 3 | $62 |
| Boston Scientific | 1 | $62 |
| Mannkind Corporation | 1 | $59 |
| Dexcom, Inc. | 3 | $39 |
| UCB, Inc. | 1 | $39 |
| Averitas Pharma Inc. | 1 | $34 |
| Pulmonx Corporation | 2 | $34 |
| Genentech USA, Inc. | 2 | $31 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Boehringer Ingelheim | 2 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Corium, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Biogen | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Inogen, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,965 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 70 | $124,339 |
| JardianceEmpagliflozin | 76 | $100,684 |
| FarxigaDapagliflozin Propanediol | 92 | $97,985 |
| OzempicSemaglutide | 42 | $92,174 |
| MounjaroTirzepatide | 61 | $85,087 |
| EliquisApixaban | 82 | $80,496 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $49,623 |
| XareltoRivaroxaban | 27 | $37,773 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 41 | $30,992 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $29,015 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $26,133 |
| EntrestoSacubitril/Valsartan | 17 | $23,664 |
| ProliaDenosumab | 11 | $20,556 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 18 | $17,987 |
| MyrbetriqMirabegron | 22 | $16,848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $1,617 | $211,141142 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $699 | $136,126143 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Synjardy Xr | $23 | $126,113106 claims |
| Novo NordiskOzempic | $701 | $92,17442 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $91 | $84,997102 claims |
| PfizerEliquis | $85 | $80,49682 claims |
| Johnson & JohnsonXarelto | $18 | $37,77327 claims |
| AmgenProlia | $65 | $20,55611 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $16,84822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Palatka
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.